The primary aim of this randomized clinical trial is to compare the effects of three different HIIT protocols and a control group on cardiometabolic health in young adults with obesity. Participants will be randomly assigned to one of the following three groups, with each having varying work-to-rest ratios: 1) HIIT-A, 2) HIIT-B, 3) HIIT-C, and 4) control group. HIIT-A, HIIT-B, and HIIT-C groups will participate in six sessions of a running based HIIT program over a 2-week training period. Pre-clinical markers of cardiovascular disease, blood lipids and fasting glucose will be measured at the following three time points: baseline, post-intervention, and 2 weeks after the training cessation (i.e., measure for detraining effect). All measurements will be performed three days before the training program and three days after the intervention to avoid the effect of the last training session. Afterwards, the detraining test will be measured 2 weeks post intervention.
Introduction: High-intensity interval training (HIIT) compared with other traditional exercise regimens has shown to be effective in improving cardiometabolic health (as measured by lipids, blood pressure \[BP\], insulin sensitivity, pulse wave velocity) in overweight and obese adults. By knowing which HIIT protocol is more efficacious in improving markers of cardiometabolic disease, exercise physiologists, researchers and clinicians can properly prescribe exercise medicine to obese young adults and possibly prevent disease progression. Therefore, the primary aim of the present research is to compare the effects of 3 different HIIT protocols compared with a control group on cardiometabolic health improvement in young adults with obesity. Participants: Participants will be randomly assigned to one of the following three groups : 1) HIIT-A (5:25 s; 1:5 ratio), 2) HIIT-B (10:50 s; 1:5 ratio), 3) HIIT-C (20:100 s; 1:5 ratio), and 4) control group. HIIT-A, HIIT-B, and HIIT-C groups will participate in six sessions of running-based HIIT programs over a 2-week training period. The variables will be measured at the following three time points: baseline, post-intervention, and 2 weeks after the TC (i.e., measure for detraining effect). High-Intensity Interval Training (six sessions over 2 weeks): Heart rate will be recorded - while performing a sprint running based on the wood court. The HIIT intensity will be set at 90% of the fastest baseline with 40 repetitions of 5-seconds work time, 20 repetitions of 10-seconds work time, or 10 repetitions of 20-seconds work time. All participants will perform one bout of sprint running for 5-, 10-, or 20- seconds followed by 25-second, 50-second, or 100-seconds resting. The supervisor will verbally encourage the running to inspire the sprint at "all-out" intensity. Note that a total of 200-seconds workout time is required per session.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
60
Intervention groups include 3 arms with 3 different HIIT protocols to identify optimal exercise regimen for improving cardiometabolic health in young adults with obesity.
Women's Building
Syracuse, New York, United States
RECRUITINGHeight
Height (cm)
Time frame: Baseline
Weight
Weight (kg); Change from Baseline weight at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Body mass index
Body mass index (kg/m2); Change from Baseline BMI at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Percentage body fat
Percentage body fat (kg); Change from Baseline percentage body fat at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Fat mass
Fat mass (kg); Change from Baseline fat mass at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Lean mass
Lean mass (kg); Change from Baseline lean mass at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Systolic blood pressure
Systolic blood pressure (SBP, mmHg); Change from Baseline SBP at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Diastolic blood pressure
Diastolic blood pressure (DBP, mmHg); Change from Baseline DBP at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Mean arterial pressure
Mean blood pressure (MAP, mmHg); Change from Baseline MAP at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Flow-mediated dilation
Flow-mediated dilation (FMD, mm); Change from Baseline FMD at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Carotid-femoral Pulse Wave Velocity (cPWV)
cPWV (m/s); Change from Baseline cPWV at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Total cholesterol
Total cholesterol (mg/dl); Change from Baseline TC at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
LDL-C
LDL-C (mg/dl); Change from Baseline LDL-C at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
HDL-C
HDL-C (mg/dl); Change from Baseline HDL-C at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Triglycerides
Triglycerides (TG, mg/dl); Change from Baseline TG at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Glucose
Glucose (mg/dl); Change from Baseline glucose at 2 week and 4 week
Time frame: Baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.